Cargando…
Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
As part of the Reproducibility Project: Cancer Biology, we published a Registered Report (Li et al., 2015), that described how we intended to replicate selected experiments from the paper ‘The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44’ (Liu et al...
Autores principales: | Yan, Xuefei, Tang, Beibei, Chen, Biao, Shan, Yongli, Yang, Huajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414201/ https://www.ncbi.nlm.nih.gov/pubmed/30860027 http://dx.doi.org/10.7554/eLife.43511 |
Ejemplares similares
-
Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Li, Jia, et al.
Publicado: (2015) -
Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44
por: Liu, Can, et al.
Publicado: (2011) -
Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021) -
Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis
por: Shao, Xuecheng, et al.
Publicado: (2021) -
Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020)